Abstract
Proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors significantly reduce low-density lipoprotein cholesterol (LDL-C) and improve the prognosis......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
